Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Coherus Bio (NQ: CHRS )

2.220 -0.080 (-3.48%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,708,561
Open 2.160
Bid (Size) 2.160 (2)
Ask (Size) 2.220 (9)
Prev. Close 2.300
Today's Range 2.060 - 2.300
52wk Range 1.430 - 10.99
Shares Outstanding 94,468,493
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Coherus BioSciences Announces CFO Transition Plans
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus Presents Phase 1/2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2023 ESMO Immuno-Oncology Congress
From Coherus BioSciences, Inc.
Via GlobeNewswire

Performance

YTD
-73.91%
-73.91%
1 Month
+38.75%
+38.75%
3 Month
-56.04%
-56.04%
6 Month
-58.74%
-58.74%
1 Year
-67.99%
-67.99%

More News

Read More
Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments
Via Talk Markets
What 6 Analyst Ratings Have To Say About Coherus BioSciences
Via Benzinga
Analyst Ratings for Coherus BioSciences
Via Benzinga
Why Coherus Biosciences Stock Dropped Today
Via The Motley Fool
Earnings Scheduled For November 6, 2023
Via Benzinga
Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical
From Coherus BioSciences, Inc.
Via GlobeNewswire
Why Coherus BioSciences Was Plummeting This Week
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Coherus BioSciences's Earnings: A Preview
Via Benzinga
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Sanmina, Adtran, Ameresco And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
From Coherus BioSciences, Inc.
Via GlobeNewswire
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
Via Talk Markets
Coherus Presents Data from Next-generation Immuno-oncology Programs at 38th Annual Meeting of Society for Immunotherapy of Cancer (SITC)
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus BioSciences to Participate at Upcoming November Investor Conferences
From Coherus BioSciences, Inc.
Via GlobeNewswire
BP, V.F. Corporation, Amkor Technology And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Coherus BioSciences to Report Third Quarter 2023 Financial Results on November 6, 2023
From Coherus BioSciences, Inc.
Via GlobeNewswire
Why Coherus BioSciences Stock Soared Today
Via The Motley Fool
Exposures Product Safety
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.